Vision loss after anti-VEGF likely to be endophthalmitis

Vision loss after anti-VEGF likely to be endophthalmitis

A review of the published case series of endophthalmitis following intravitreal injection indicates that those presenting with visual acuity 20/200 or less more than 24 hours after the injection were very likely to have endophthalmitis, while those presenting with a similar loss of vision during the first 24 hours were more likely to be due to different causes. The study's investigators used a Pubmed search of the literature and retrieved 12 case series, which together with their own case series included a total of 133 patients. The researchers found that the records showed that among those cases where antibiotics were deemed unnecessary the mean time to presentation was one day, but in those who received antibiotics the mean time to presentation was three days, whether or not their biopsy was positive for bacterial pathogens.
• (Hoevenaars et al, Ophthalmologica 2012, DOI: 10.1159/000339584.) 

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...